Has Asa Mair received payments from drug or device companies?

Yes. Drug and device makers reported $5,085 in general payments to Asa Mair across 291 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asa Mair did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asa Mair come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asa Mair

Physician Assistant · Monroe, NCNPI 1306458062

Payments from drug & device makers

$5,085in general payments, 2019–2025

Across 291 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$729
Otsuka America Pharmaceutical, Inc.$685
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$633
Teva Pharmaceuticals USA, Inc.$416
Axsome Therapeutics, Inc.$376
Alkermes, Inc.$348
plus $2K from 18 others

What the payments were for

Food & beverage$4,91097%
Education$1613%
Other$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	31	$729
Otsuka America Pharmaceutical, Inc.	52	$685
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	36	$633
Teva Pharmaceuticals USA, Inc.	20	$416
Axsome Therapeutics, Inc.	19	$376
Alkermes, Inc.	24	$348
AbbVie	24	$333
Vanda Pharmaceuticals Inc.	15	$205
Neurocrine Biosciences, Inc.	7	$178
Corium, LLC	7	$172
Johnson & Johnson	7	$167
E.r. Squibb & Sons, L.L.C.	14	$162
Neos Therapeutics, LP	6	$105
Lundbeck LLC	6	$100
Idorsia Pharmaceuticals US Inc	4	$81
Alk-abello, Inc	1	$75
Collegium Pharmaceutical, Inc.	4	$67
Ironshore Pharmaceuticals Inc.	3	$59
Takeda Pharmaceuticals U.S.A., Inc.	4	$59
Tris Pharma Inc	2	$47
Noven Therapeutics, LLC	2	$38
Vertical Pharmaceuticals, LLC	1	$19
Almatica Pharma LLC	1	$16
Welch Allyn	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$213

How this compares

$5,085 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Eszopiclone	17	$1,889
Lurasidone Hcl	21	$1,572
Aripiprazole	21	$620
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	14	$535
Trazodone Hcl	33	$250
Prazosin Hcl	13	$181
Fluoxetine Hcl	19	$143
Clonazepam	21	$42

Paid to pharmacies, not to this prescriber.

Other physician assistant in Monroe

Jo HughesGreensboro$814K
Rachel HolzhauerCharlotte$739K
Amber BlairCharlotte$551K
Benjamin EpsteinDavidson$447K
Rebecca KrausDavidson$425K
Brooke JonesGoldsboro$259K
Philip ReasbeckWilson$180K
Katherine SchultzHuntersville$164K
Kristin CabedaCharlotte$135K
Jay ClarkeArden$133K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →